Last Posted: Jan 15, 2020
- Convolution neural network-based Alzheimer's disease classification using hybrid enhanced independent component analysis based segmented gray matter of T2 weighted magnetic resonance imaging with clinical valuation.
Basheera Shaik et al. Alzheimer's & dementia (New York, N. Y.) 2019 5974-986 - Temporal association of neuropsychological test performance using unsupervised learning reveals a distinct signature of Alzheimer's disease status.
Joshi Prajakta S et al. Alzheimer's & dementia (New York, N. Y.) 2019 5964-973 - Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques.
Ezzati Ali et al. Journal of Alzheimer's disease : JAD 2019 Dec - The causes and consequences of Alzheimer's disease: A Mendelian randomization analysis
BIORXIV, December 2019 - Spatial-Temporal Dependency Modeling and Network Hub Detection for Functional MRI Analysis via Convolutional-Recurrent Network.
Wang Mingliang et al. IEEE transactions on bio-medical engineering 2019 Dec - Epidemiological pathology of Aβ deposition in the ageing brain in CFAS: addition of multiple Aβ-derived measures does not improve dementia assessment using logistic regression and machine learning approaches.
Wharton S B et al. Acta neuropathologica communications 2019 Dec 7(1) 198 - The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases.
Son Hye Joo et al. European journal of nuclear medicine and molecular imaging 2019 Dec - Active Immunotherapy to Prevent Alzheimer Disease—A DNA Amyloid β 1-42 Trimer Vaccine
RN Rosenberg et al, JAMA Neurology, December 9, 2019 - Using a genetic risk score to estimate the earliest age of Alzheimer's disease-related physiologic change in Body Mass Index
W Brenowitz, et al, MedRXIV, December 2019 - Genetic testing for Alzheimer's disease: trends, challenges and ethical considerations.
Rentería Miguel E et al. Current opinion in psychiatry 2019 Nov
.png)
No hay comentarios:
Publicar un comentario